Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wallac is a Finland-based life science and diagnostics company best known for assay, screening, and laboratory instrumentation technologies developed in Turku. Historically an independent technology company founded in 1950, Wallac became part of larger corporate groups and today operates as Wallac Oy within Revvity's diagnostics and life sciences organization. The business is primarily focused on commercial in vitro diagnostics, newborn and maternal-fetal screening, assay reagents, and laboratory instruments rather than therapeutic drug development. Its Turku site is a major manufacturing and product-development center supporting global screening and diagnostic products. Wallac is particularly associated with DELFIA time-resolved fluorescence immunoassay technology and related screening systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wallac.